Generative AI

A new strategic partnership aims to dominate the APAC market by integrating displays and AI cameras, promising a frictionless future for meeting rooms.

Azores Labs launches Jumpo, an AI-powered kids' camera blending creativity and safety. But can it win over parents in a competitive tech market?

ASUS sets the stage for CES 2026 with a dual-screen Zenbook DUO and a durable ProArt laptop co-engineered with GoPro, all powered by a new AI vision.

AI drug discovery firm Insilico Medicine soars in its Hong Kong debut, the city's largest biotech IPO of 2025, validating a new tech-driven era for medicine.

As AI tools multiply, Cloudhands emerges with a unified platform and veteran leadership, promising to end the chaos of juggling multiple models.

DAREU is set to unveil three high-performance peripherals at CES 2026, combining advanced magnetic switches with an aggressive global expansion strategy.

With industry veteran Don Cantow at the helm, Altium aims to unify electronics design on an open platform, accelerating its post-Renesas acquisition strategy.

When a family business faced collapse, an unlikely successor returned. Now, Shuhui Mai is rebuilding it from the ground up with bold design and a new vision.

reAlpha Mortgage is offering stock ownership and AI assistants to attract loan officers, a move that could disrupt traditional industry compensation.

Esports giant OverActive Media is raising fresh capital. Is this a strategic push into AI and esports dominance or a necessary move to shore up its finances?

With strong financials and new clinical data, medical device leader Penumbra is set to detail its growth strategy at healthcare's top investor event.

After a year of major acquisitions and AI-driven innovation, all eyes are on Labcorp's strategic vision for 2026 at the J.P. Morgan Healthcare Conference.

As 10x Genomics preps for its J.P. Morgan spotlight, investors seek a clear path to profit amid fierce competition and groundbreaking innovation.

Amidst legal industry fears of generative AI, BriefCatch's $6M funding and stellar retention prove the value of a trusted, specialized AI writing partner.

PacBio heads to J.P. Morgan's conference with new tech aimed at making long-read sequencing cheaper. Can it challenge rivals and win over investors?

SOLAI shareholders approved a massive 30 billion share increase, arming the firm for a radical pivot into AI and the Solana ecosystem. But what about dilution?

Profound Medical raises over $42M to advance its AI-powered, incision-free therapies for cancer and other diseases, signaling strong investor confidence.

As Axos sets to reveal its Q2 results, investors weigh strong growth forecasts against mounting concerns over margin pressure and a shifting economy.

As data centers face an energy crisis fueled by AI, Aradatum is commercializing a unique vertical wind turbine promising a dense, low-cost power solution.

Facing stock pressure, Dot Ai bets on seasoned sales leader Delores Rochester to scale its enterprise business in the booming Asset Intelligence market.